Piramal Pharma Share Sale: America’s non-public fairness agency Carlile Group is getting ready to promote as much as 10 p.c stake in India’s Piramal Pharma by block offers. Moneycontrol has come to know from sources that by this share sale, Carlile can earn round Rs 2,600-2,700 crore. Carlile purchased a 20 p.c stake in Piramal Pharma for Rs 3,523 crore in June 2020. Inventory trade information exhibits that by 31 March 2025, Carlil had 18 p.c stake in Piramal Pharma. On the present market worth it sits price Rs 4,836 crore. Funding Financial institution Motilal Oswal has been appointed as a dealer for block trades. Piramal Pharma Share, a 27 p.c climbing Khabarmal Pharma shares closed at Rs 202.40 on 3 July at Rs 202.40. The corporate’s market cap is near Rs 27000 crore. The face worth of the inventory is Rs 10. The inventory has gained 124 p.c in 2 years. It has seen a development of 27 p.c in a 12 months. On the identical time, the value has been 20 p.c cheaper in 6 months and 12 p.c cheaper in 3 months. The corporate had a 34.95 p.c stake within the firm until the tip of March 2025. Within the month of month-to-month, Selection Broking gave a goal worth of Rs 235 per share with a ‘by’ ranking for the inventory. Motilal Oswal gave a goal of Rs 250, repeating the ‘bye’ ranking. Just lately, Goldman Sachs additionally set a goal worth of Rs 265 with a ‘bye’ ranking. How a lot Munafapiramal Pharma’s January-March 2025 within the March quarter was Rs 1,689.80 crore, web revenue of Rs 277.27 crore and earnings per share at Standalone Bay within the January-March 2025 quarter. In FY 2024-25, the corporate’s income was recorded at Rs 5,285.71 crore, web revenue of Rs 691.40 crore and earnings per share of Rs 5.22 crore. The fifth annual basic assembly of Piramal Pharma goes to be held on 30 July 2025. MRF goes to present a ultimate dividend of ₹ 229, report date for fastened The report date for that is 16 July. By this date, shareholders whose names might be within the data of the Register of Members of the Firm or Depositors because the beneficiaries house owners of shares might be entitled to dividend. Piramal Pharma gave a ultimate dividend of 11 paise to shareholders for FY 2024. Disclaimer: The recommendation or thought given on Moneycontrol.com has their very own private views of consultants/brokerage corporations. The web site or administration will not be accountable for this. Moneycontrol advises to customers that at all times search the recommendation of licensed consultants earlier than taking any funding determination.
